chloroquine has been researched along with Deficiency, Glucosephosphatase in 4 studies
Chloroquine: The prototypical antimalarial agent with a mechanism that is not well understood. It has also been used to treat rheumatoid arthritis, systemic lupus erythematosus, and in the systemic therapy of amebic liver abscesses.
chloroquine : An aminoquinoline that is quinoline which is substituted at position 4 by a [5-(diethylamino)pentan-2-yl]amino group at at position 7 by chlorine. It is used for the treatment of malaria, hepatic amoebiasis, lupus erythematosus, light-sensitive skin eruptions, and rheumatoid arthritis.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The primary outcome was the incidence of severe haemolysis or other serious adverse events (SAEs)." | 2.71 | Safety of the methylene blue plus chloroquine combination in the treatment of uncomplicated falciparum malaria in young children of Burkina Faso [ISRCTN27290841]. ( Burhenne, J; Coulibaly, B; Jahn, A; Kouyaté, B; Mandi, G; Mansmann, U; Meissner, PE; Mikus, G; Müller, O; Rengelshausen, J; Riedel, KD; Sanon, M; Schiek, W; Schirmer, H; Tapsoba, T; Walter-Sack, I; Witte, S, 2005) |
| "Primaquine was officially licensed as an anti-malarial drug by the FDA in 1952." | 2.47 | Primaquine in vivax malaria: an update and review on management issues. ( Fernando, D; Rajapakse, S; Rodrigo, C, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fernando, D | 1 |
| Rodrigo, C | 1 |
| Rajapakse, S | 1 |
| Meissner, PE | 1 |
| Mandi, G | 1 |
| Witte, S | 1 |
| Coulibaly, B | 1 |
| Mansmann, U | 1 |
| Rengelshausen, J | 1 |
| Schiek, W | 1 |
| Jahn, A | 1 |
| Sanon, M | 1 |
| Tapsoba, T | 1 |
| Walter-Sack, I | 1 |
| Mikus, G | 1 |
| Burhenne, J | 1 |
| Riedel, KD | 1 |
| Schirmer, H | 1 |
| Kouyaté, B | 1 |
| Müller, O | 1 |
| Rebholz, CE | 1 |
| Michel, AJ | 1 |
| Maselli, DA | 1 |
| Saipphudin, K | 1 |
| Wyss, K | 1 |
| Handa, R | 1 |
| Wig, N | 1 |
| Aggarwal, P | 1 |
| Suresh, V | 1 |
| Biswas, A | 1 |
| Wali, JP | 1 |
1 review available for chloroquine and Deficiency, Glucosephosphatase
| Article | Year |
|---|---|
Primaquine in vivax malaria: an update and review on management issues.
Topics: Aminoquinolines; Antimalarials; Artemisinins; Chloroquine; Clinical Trials as Topic; Drug Resistance | 2011 |
1 trial available for chloroquine and Deficiency, Glucosephosphatase
| Article | Year |
|---|---|
Safety of the methylene blue plus chloroquine combination in the treatment of uncomplicated falciparum malaria in young children of Burkina Faso [ISRCTN27290841].
Topics: Burkina Faso; Child, Preschool; Chloroquine; Drug Therapy, Combination; Glycogen Storage Disease Typ | 2005 |
2 other studies available for chloroquine and Deficiency, Glucosephosphatase
| Article | Year |
|---|---|
Frequency of malaria and glucose-6-phosphate dehydrogenase deficiency in Tajikistan.
Topics: Adult; Chloroquine; Glycogen Storage Disease Type I; Hemolysis; Humans; Malaria; Malaria, Vivax; Mal | 2006 |
Halofantrine in G-6 PD deficiency.
Topics: Aged; Antimalarials; Chloroquine; Glycogen Storage Disease Type I; Hemolysis; Humans; Malaria, Falci | 1997 |